Bayesian Capital Management’s Medifast MED Stock Holding History

Bayesian Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-714	Closed	-$202K	–	477
2021 Q2	$202K	Buy	+714	New	+$193K	0.05%	366
2018 Q4	–	Sell	-10,692	Closed	-$2.37M	–	715
2018 Q3	$2.37M	Buy	10,692 +2,700	+34%	+$547K	0.39%	58
2018 Q2	$1.28M	Buy	7,992 +5,382	+206%	+$688K	0.29%	88
2018 Q1	$244K	Sell	2,610 -1,135	-30%	-$84.8K	0.06%	449
2017 Q4	$261K	Buy	+3,745	New	+$248K	0.05%	440

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bayesian Capital Management's MED Position: Q3 2021 in Review

Bayesian Capital Management sold out of Medifast (MED) in Q3 2021, closing a stake of 714 shares — an estimated $202K sold.

Bayesian Capital Management first reported a position in MED in Q4 2017 and held it in 5 quarters. The position peaked at $2.37M in Q3 2018. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

Bayesian Capital Management reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
Bayesian Capital Management sold 714 Medifast shares in Q3 2021, an estimated $202K.
Bayesian Capital Management first reported a position in Medifast in Q4 2017 and held it in 5 quarters.
Bayesian Capital Management's Medifast position peaked at $2.37M in Q3 2018.
296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Bayesian Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.